Suppression of body fat accumulation in myostatin-deficient mice
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Myostatin is a TGF-β family member that acts as a negative regulator of muscle growth. Mice lacking the myostatin gene (Mstn) have a widespread increase in skeletal muscle mass resulting from a combination of muscle fiber hypertrophy and hyperplasia. Here we show that Mstn-null mice have a significant reduction in fat accumulation with increasing age compared with wild-type littermates, even in the setting of normal food intake (relative to body weight), normal body temperature, and a slightly decreased resting metabolic rate. To investigate whether myostatin might be an effective target for suppressing the development of obesity in settings of abnormal fat accumulation, we analyzed the effect of the Mstn mutation in two genetic models of obesity, agouti lethal yellow (Ay) and obese (Lepob/ob). In each case, loss of Mstn led to a partial suppression of fat accumulation and of abnormal glucose metabolism. Our findings raise the possibility that pharmacological agents that block myostatin function may be useful not only for enhancing muscle growth, but also for slowing or preventing the development of obesity and type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Germline deletion of myostatin is viable and in several species shows a benefit not only in increased muscularity, but also in metabolic parameters51,52.”
From GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates (2025) · cites this paper as [51]
In the citing paper
“For example, myostatin knockout mice [21] or mice in which constitutively active Akt1 is expressed only in skeletal muscle [22] have not only more skeletal muscle mass but also less fat mass and improved glucose homeostasis when compared with wild-type controls.”
From Effects of Skeletal Muscle Hypertrophy on Fat Mass and Glucose Homeostasis in Humans and Animals: A Narrative Review with Systematic Literature Search (2025) · cites this paper as [21]
In the citing paper
“If Mstn is knocked out in a diabetic, overweight mouse strain, then this not only results in muscle hypertrophy but additionally causes profound fat loss and improves glucose homeostasis after a glucose challenge [21].”
From Effects of Skeletal Muscle Hypertrophy on Fat Mass and Glucose Homeostasis in Humans and Animals: A Narrative Review with Systematic Literature Search (2025) · cites this paper as [21]
In the citing paper
“A decrease of circulating myostatin can explain fat loss and improved glucose homeostasis, as this is a phenotype of Mstn−/− mice [21].”
From Effects of Skeletal Muscle Hypertrophy on Fat Mass and Glucose Homeostasis in Humans and Animals: A Narrative Review with Systematic Literature Search (2025) · cites this paper as [21]
Citations
Cites
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Self-citationTGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Self-citationTowards a molecular understanding of adaptive thermogenesis
Lowell, B. B., & Spiegelman, B. M. (2000) · Nature · doi:10.1038/35007527 · Cited by 1,630
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
Self-citationA deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice
Coleman, D. L. (1978) · Diabetologia · doi:10.1007/bf00429772 · Cited by 1,307
Research works printed but not linked: 1
- Kahn, 1994, Diabetes, 43, 1066, 10.2337/diabetes.43.4.587 · doi:10.2337/diabetes.43.4.587 · Paper page
Cited by
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909
Adipocyte differentiation from the inside out
Rosen, E. D., & MacDougald, O. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2066 · Cited by 2,607
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Self-citationThe Human Obesity Gene Map: The 2005 Update
Rankinen, T., Zuberi, A., Chagnon, Y. C., Weisnagel, S. J., Argyropoulos, G., Walts, B., Pérusse, L., & Bouchard, C. (2006) · Obesity · doi:10.1038/oby.2006.71 · Cited by 1,119
“2 GDF8 Growth differentiation factor 8, also known as myostatin Reduced adiposity and increased muscle mass Loss of Gdf8 expression also results in a significant reduction in adipose mass accumulation in agouti lethal yellow (A) and Lep mutants (383,384)”
BackgroundREGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819
Self-citationExercise is the real polypill.
Fiuza-Luces, C., Garatachea, N., Berger, N. A., & Lucia, A. (2013) · Physiology · doi:10.1152/physiol.00019.2013 · Cited by 791
“Although myostatin increases might contribute to insulin resistance (184, 360), obesity (185), muscle wasting (63, 70, 97, 154), or agingsarcopenia (523), its loss/inhibition decreases adiposity (164, 303, 521, 530), induces browning of the white adipose tissue [through AMPK-peroxisome proliferator-activated receptor-…”
BackgroundMyostatin negatively regulates satellite cell activation and self-renewal
McCroskery, S., Thomas, M., Maxwell, L., Sharma, M., & Kambadur, R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207056 · Cited by 784
“persistent postnatal muscle growth and lack of muscle wasting observed in myostatin-null mice (McPherron and Lee, 2002).”
BackgroundProtection from obesity and diabetes by blockade of TGF-β/smad3 signaling
Yadav, H., Quijano, C., Kamaraju, A. K., Gavrilova, O., Malek, R., Chen, W., Zerfas, P., Zhigang, D., Wright, E. C., Stuelten, C., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.013 · Cited by 709
“These studies, altogether, suggest an important role for TGF-b superfamily members in WAT and BAT biology, akin to the role of myostatin in muscle development (McPherron and Lee, 2002).”
BackgroundInfluentialTargeting senescent cells enhances adipogenesis and metabolic function in old age
Xu, M., Palmer, A. K., Ding, H., Weivoda, M. M., Pirtskhalava, T., White, T. A., Sepe, A., Johnson, K. O., Stout, M. B., Giorgadze, N., et al. (2015) · eLife · doi:10.7554/elife.12997 · Cited by 604
“These agents would therefore be anticipated to alter both muscle and fat mass though additional mechanisms that may be independent of activin A (Lee, 2004; McPherron and Lee, 2002).”
BackgroundA review on the mechanisms of blood-flow restriction resistance training-induced muscle hypertrophy
Pearson, S. J., & Hussain, S. R. (2015) · Sports Medicine · doi:10.1007/s40279-014-0264-9 · Cited by 592
“Myostatin is a member of the transforming growth factor (TGF)-b super-family that negatively regulates muscle growth [127–132] via the Smad2/3 phosphorylationinduced inhibition of myoblast and myotube differentiation [133–136].”
BackgroundRebbapragada, A., Benchabane, H., Wrana, J. L., Celeste, A. J., & Attisano, L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7230-7242.2003 · Cited by 565
“Since decreased fat accumulation is observed both in knock-out mice that lack myostatin and in wild-type adult mice in which myostatin has been systemically administered (28, 38), it appears that myostatin may play distinct physiological roles during early development and during adult homeostatic processes.”
BackgroundSignaling pathways controlling skeletal muscle mass
Egerman, M. A., & Glass, D. J. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.857291 · Cited by 555
“…and other TGFb family members Myostatin, or growth and differentiation factor 8 (GDF-8), is a member of the transforming growth factor-b (TGF-b) superfamily that acts as a negative regulator of muscle growth (Lee & McPherron, 1999, 2001; McPherron & Lee, 1997, 2002; McPherron et al., 1997, 1999).”
BackgroundPedersen, B. K. (2013) · Comprehensive physiology · doi:10.1002/cphy.c120033 · Cited by 516
Peroxisome proliferator‐activated receptor δ controls muscle development and oxydative capability
Luquet, S., Lopez‐Soriano, J., Holst, D., Fredenrich, A., Melki, J., Rassoulzadegan, M., & Grimaldi, P. A. (2003) · The FASEB Journal · doi:10.1096/fj.03-0269fje · Cited by 509
Inhibition of myostatin in adult mice increases skeletal muscle mass and strength
Whittemore, L.-A., Song, K., Li, X., Aghajanian, J., Davies, M., Girgenrath, S., Hill, J. J., Jalenak, M., Kelley, P., Knight, A., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02953-4 · Cited by 503
“This result differs from the results reported for the myostatin knockout mice in which fat accumulation is decreased in the absence of myostatin [5,6].”
BackgroundResultRegulation of muscle growth by multiple ligands signaling through activin type II receptors
Lee, S.-J., Reed, L. A., Davies, M. V., Girgenrath, S., Goad, M. E. P., Tomkinson, K. N., Wright, J. F., Barker, C., Ehrmantraut, G., Holmstrom, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505996102 · Cited by 501
Self-citationMitochondrial dysfunction in obesity
Bournat, J. C., & Brown, C. W. (2010) · Current Opinion in Endocrinology, Diabetes and Obesity · doi:10.1097/med.0b013e32833c3026 · Cited by 470
“Gdf8 (myostatin)-null mice have increased muscle mass, are resistant to dietinduced obesity, and have improved insulin sensitivity [83,84].”
BackgroundActivation of latent myostatin by the BMP-1/tolloid family of metalloproteinases
Wolfman, N. M., McPherron, A. C., Pappano, W. N., Davies, M. V., Song, K., Tomkinson, K. N., Wright, J. F., Zhao, L., Sebald, S. M., Greenspan, D. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2534946100 · Cited by 454
Self-citationDeterminants of meat quality: tenderness
Maltin, C., Balcerzak, D., Tilley, R., & Delday, M. (2003) · Proceedings of the Nutrition Society · doi:10.1079/pns2003248 · Cited by 448
Hill, J. J., Davies, M. V., Pearson, A. A., Wang, J. H., Hewick, R. M., Wolfman, N. M., & Qiu, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206379200 · Cited by 443
Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise
Schnyder, S., & Handschin, C. (2015) · Bone · doi:10.1016/j.bone.2015.02.008 · Cited by 419
“in thesemice [64,65] hence suggesting that despite decreased leptin secretion, myostatin null mice are protected from the counter-regulatory”
BackgroundExercise Attenuates the Major Hallmarks of Aging
Garatachea, N., Pareja-Galeano, H., Sanchis-Gomar, F., Santos-Lozano, A., Fiuza-Luces, C., Morán, M., Emanuele, E., Joyner, M. J., & Lucia, A. (2015) · Rejuvenation Research · doi:10.1089/rej.2014.1623 · Cited by 413
Guo, T., Jou, W., Chanturiya, T., Portas, J., Gavrilova, O., & McPherron, A. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004937 · Cited by 402
“Mice null for both Mstn and leptin have a mild decrease in adipose tissue compared to leptin null mice, but this improvement is found only in young animals [18].”
InfluentialSelf-citationFast/Glycolytic Muscle Fiber Growth Reduces Fat Mass and Improves Metabolic Parameters in Obese Mice
Izumiya, Y., Hopkins, T., Morris, C., Sato, K., Zeng, L., Viereck, J., Hamilton, J. A., Ouchi, N., LeBrasseur, N. K., & Walsh, K. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.003 · Cited by 395
“A ketogenic diet leads to reductions in body weight exchange ratio (McPherron and Lee, 2002).”
BackgroundInfluentialLi, W., Kennedy, S. G., & Ruvkun, G. (2003) · Genes & Development · doi:10.1101/gad.1066503 · Cited by 372
“A nearly congruent mammalian TGF signaling pathway has also been detected in mammals, and although its regulation of metabolism and convergence with insulin signaling have not yet been noted, there are indications that these pathways do intersect (McPherron et al. 1997; McPherron and Lee 2002).”
BackgroundForde, N., Carter, F., Fair, T., Crowe, M. A., Evans, A. C. O., Spencer, T. E., Bazer, F. W., McBride, R., Boland, M. P., O'Gaora, P., et al. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.074336 · Cited by 366
“Mstn-null mice display reduced fat accumulation and abnormal glucose metabolism [28], and in vitro treatment of human term placenta resulted in increased deoxyglucose uptake [29].”
BackgroundSatellite cells in human skeletal muscle plasticity
Snijders, T., Nederveen, J. P., McKay, B. R., Joanisse, S., Verdijk, L. B., van Loon, L. J. C., & Parise, G. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00283 · Cited by 359
“Myostatin is a member of the transforming growth factor-β (TGF-β) superfamily and acts as a potent negative regulator of skeletal muscle growth (McPherron et al., 1997; McPherron and Lee, 2002).”
BackgroundThe role of myostatin in muscle wasting: an overview
Elkina, Y., von Haehling, S., Anker, S. D., & Springer, J. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0035-5 · Cited by 348
“Moreover, Mstn null mice had a decreased amount of adipose tissue [14, 32].”
BackgroundA brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)
Siddiqui, S., Mateen, S., Ahmad, R., & Moin, S. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02625-7 · Cited by 347
Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin
Reisz-Porszasz, S., Bhasin, S., Artaza, J. N., Shen, R., Sinha-Hikim, I., Hogue, A., Fielder, T. J., & Gonzalez-Cadavid, N. F. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00107.2003 · Cited by 333
“However, myostatin protein has opposite effects on muscle and fat mass: it decreases muscle mass but increases fat mass (25), so that myostatin may actually affect stages prior to myogenesis itself.”
BackgroundResultThe Human Obesity Gene Map: The 2004 Update
Pérusse, L., Rankinen, T., Zuberi, A., Chagnon, Y. C., Weisnagel, S. J., Argyropoulos, G., Walts, B., Snyder, E. E., & Bouchard, C. (2005) · Obesity Research · doi:10.1038/oby.2005.50 · Cited by 330
Quadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling Pathways
Lee, S.-J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000789 · Cited by 316
Self-citationTransforming growth factor-β and myostatin signaling in skeletal muscle
Kollias, H. D., & McDermott, J. C. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01091.2007 · Cited by 307
AgRP Neurons Control Systemic Insulin Sensitivity via Myostatin Expression in Brown Adipose Tissue
Steculorum, S. M., Ruud, J., Karakasilioti, I., Backes, H., Engström Ruud, L., Timper, K., Hess, M. E., Tsaousidou, E., Mauer, J., Vogt, M. C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.044 · Cited by 277
“Importantly, myostatin expression is upregulated in obesity and myostatin-deficient mice exhibit increased muscle mass, decreased adiposity, and increased insulin sensitivity (McPherron and Lee, 2002).”
BackgroundGonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278
Inter-organ cross-talk in metabolic syndrome
Priest, C., & Tontonoz, P. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0145-5 · Cited by 279
Bone and Muscle Endocrine Functions: Unexpected Paradigms of Inter-organ Communication
Karsenty, G., & Olson, E. N. (2016) · Cell · doi:10.1016/j.cell.2016.02.043 · Cited by 275
“Thus, mice lacking myostatin display reduced fat mass and improved insulin sensitivity (McPherron and Lee, 2002).”
BackgroundThe Ever-Expanding Myokinome: Discovery Challenges and Therapeutic Implications
Whitham, M., & Febbraio, M. A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.153 · Cited by 279
TGF-β Family Signaling in Mesenchymal Differentiation
Grafe, I., Alexander, S., Peterson, J. R., Snider, T. N., Levi, B., Lee, B., & Mishina, Y. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022202 · Cited by 272
Oversecretion of interleukin-15 from skeletal muscle reduces adiposity
Quinn, L. S., Anderson, B. G., Strait-Bodey, L., Stroud, A. M., & Argilés, J. M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90506.2008 · Cited by 267
“Mice and cattle with induced or natural deletion of functional myostatin have decreased adipose tissue mass (43, 44).”
BackgroundThe origin of intermuscular adipose tissue and its pathophysiological implications
Vettor, R., Milan, G., Franzin, C., Sanna, M., De Coppi, P., Rizzuto, R., & Federspil, G. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00229.2009 · Cited by 261
“It acts as strong negative regulator of myogenesis (50, 69, 79), and the lack of it leads to a decreased adipogenesis and to a reduction of fat accumulation, observed also in animal models of obesity (69, 80), suggesting its important role in metabolism.”
BackgroundClinical, Agricultural, and Evolutionary Biology of Myostatin: A Comparative Review
Rodgers, B. D., & Garikipati, D. K. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0003 · Cited by 237
“Circulating levels of leptin, an adipokine and satiety factor that controls body fat, are reduced rather than elevated in these animals (56, 228).”
BackgroundInfluentialZhu, X., Topouzis, S., Liang, L.-F., & Stotish, R. L. (2004) · Cytokine · doi:10.1016/j.cyto.2004.03.007 · Cited by 230
Hill, J. J., Qiu, Y., Hewick, R. M., & Wolfman, N. M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0366 · Cited by 225
Dong, J., Dong, Y., Dong, Y., Chen, F., Mitch, W. E., & Zhang, L. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.200 · Cited by 212
“Recent studies indicate that the influence of myostatin extends beyond influencing muscle growth: over expression of myostatin in mice causes insulin resistance while genetic deletion of myostatin prevents obesity even though myostatin is expressed at a low level in adipose tissues (7-9).”
BackgroundMetabolic adaptation in obesity and type ii diabetes: myokines, adipokines and hepatokines
Oh, K.-J., Lee, D., Kim, W., Han, B., Lee, S., & Bae, K.-H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010008 · Cited by 210
“Myostatin depletion leads to skeletal muscle hypertrophy and a reduction in total body fat [81,82].”
BackgroundSelf-citationMyostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects
Feldman, B. J., Streeper, R. S., Farese, R. V., & Yamamoto, K. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607501103 · Cited by 210
Generation of gene-modified goats targeting MSTN and FGF5 via zygote injection of CRISPR/Cas9 system
Wang, X., Yu, H., Lei, A., Zhou, J., Zeng, W., Zhu, H., Dong, Z., Niu, Y., Shi, B., Cai, B., et al. (2015) · Scientific Reports · doi:10.1038/srep13878 · Cited by 207
Expression and function of myostatin in obesity, diabetes, and exercise adaptation
ALLEN, D. L., HITTEL, D. S., & MCPHERRON, A. C. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182178bb4 · Cited by 207
“Crossing myostatin null mice with genetically obese ob/ob or agouti lethal yellow mice attenuated the increased adipose mass, hyperglycemia, hyperlipidemia, and hyperinsulinemia typically observed in these genetically obese animals (41).”
Self-citationDominique, J.-E., & Gérard, C. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.04.012 · Cited by 207
Artaza, J. N., Bhasin, S., Magee, T. R., Reisz-Porszasz, S., Shen, R., Groome, N. P., Fareez, M. M., & Gonzalez-Cadavid, N. F. (2005) · Endocrinology · doi:10.1210/en.2005-0362 · Cited by 207
“Our results in the C3H 10T(1/2) cell line agree with the fact that skeletal muscle is considerably increased, whereas fat tissue is reduced, when the Mst gene is inactivated in mice (5, 6) and humans (7).”
ResultMyostatin Inhibits IGF-I-Induced Myotube Hypertrophy through Akt
Morissette, M. R., Cook, S. A., Buranasombati, C., Rosenberg, M. A., & Rosenzweig, A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00043.2009 · Cited by 231
“MSTN KO mice also display reduced adipose tissue (21).”
BackgroundZamani, N., & Brown, C. W. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0018 · Cited by 202
Dubois, V., Laurent, M., Boonen, S., Vanderschueren, D., & Claessens, F. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0883-3 · Cited by 197
Argilés, J. M., López-Soriano, J., Almendro, V., Busquets, S., & López-Soriano, F. J. (2005) · Medicinal Research Reviews · doi:10.1002/med.20010 · Cited by 194
Zhang, C., McFarlane, C., Lokireddy, S., Masuda, S., Ge, X., Gluckman, P. D., Sharma, M., & Kambadur, R. (2012) · Diabetologia · doi:10.1007/s00125-011-2304-4 · Cited by 192
“Furthermore, loss of myostatin in genetic models of obesity (agouti lethal yellow and leptindeficient mice [Lep]) suppressed body fat accumulation [7].”
BackgroundMyostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review
White, T. A., & LeBrasseur, N. K. (2014) · Gerontology · doi:10.1159/000356740 · Cited by 191
Qian, L., Tang, M., Yang, J., Wang, Q., Cai, C., Jiang, S., Li, H., Jiang, K., Gao, P., Ma, D., et al. (2015) · Scientific Reports · doi:10.1038/srep14435 · Cited by 189
Exercise-Induced Myokines With Therapeutic Potential for Muscle Wasting
Piccirillo, R. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00287 · Cited by 189
Crosstalk between adipokines and myokines in fat browning
Rodríguez, A., Becerril, S., Ezquerro, S., Méndez‐Giménez, L., & Frühbeck, G. (2017) · Acta Physiologica · doi:10.1111/apha.12686 · Cited by 188
“Accordingly, the absence of myostatin in genetic models of obesity, such as leptin-deficient ob/ob or agouti lethal yellow (Ay/a) mice, partially suppresses both fat accumulation and the development of hyperglycaemia (McPherron & Lee 2002).”
BackgroundTransgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance
Zhao, B., Wall, R. J., & Yang, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.044 · Cited by 186
“Myostatin-deficiency in mice reduces fat accumulation with increasing age on a regular rodent chow [19].”
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies
Kornegay, J. N., Bogan, J. R., Bogan, D. J., Childers, M. K., Li, J., Nghiem, P., Detwiler, D. A., Larsen, C. A., Grange, R. W., Bhavaraju-Sanka, R. K., et al. (2012) · Mammalian Genome · doi:10.1007/s00335-011-9382-y · Cited by 186
“Lee and colleagues have shown that the myostatin gene (growth/differentiation factor 8) is a key negative regulator of muscle growth (McPherron et al. 1997; Lee and McPherron 1999; Lee 2004; McPherron and Lee 2002).”
Camporez, J.-P. G., Petersen, M. C., Abudukadier, A., Moreira, G. V., Jurczak, M. J., Friedman, G., Haqq, C. M., Petersen, K. F., & Shulman, G. I. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525795113 · Cited by 184
“In particular, myostatin knockout mice with marked skeletal muscle hypertrophy displayed increased energy expenditure (16, 17).”
BackgroundAllen, D. L., Cleary, A. S., Speaker, K. J., Lindsay, S. F., Uyenishi, J., Reed, J. M., Madden, M. C., & Mehan, R. S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00798.2007 · Cited by 183
“Second, in addition to their remarkable hypermuscular phenotype, MSTN-null mice also have a striking diminution in adipose tissue content (21, 24), and MSTN inactivation also partly suppresses fat accumulation in two murine genetic models of obesity (24).”
BackgroundThe central role of myostatin in skeletal muscle and whole body homeostasis
Elliott, B., Renshaw, D., Getting, S., & Mackenzie, R. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2012.02423.x · Cited by 183
“Lin et al. (2002) and McPherron & Lee (2002) noted that myostatin / mice had significantly reduced levels of subcutaneous body fat, with Lin et al. (2002) further noting that myostatin / mice showed decreased leptin concentrations.”
Modulating skeletal muscle mass by postnatal, muscle‐specific inactivation of the myostatin gene
Grobet, L., Pirottin, D., Farnir, F., Poncelet, D., Royo, L. J., Brouwers, B., Christians, E., Desmecht, D., Coignoul, F., Kahn, R., et al. (2003) · genesis · doi:10.1002/gene.10188 · Cited by 180
Proteomic analysis of bovine skeletal muscle hypertrophy
Bouley, J., Meunier, B., Chambon, C., De Smet, S., Hocquette, J. F., & Picard, B. (2005) · PROTEOMICS · doi:10.1002/pmic.200400925 · Cited by 168
Metspalu, M., Romero, I. G., Yunusbayev, B., Chaubey, G., Mallick, C. B., Hudjashov, G., Nelis, M., Mägi, R., Metspalu, E., Remm, M., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.010 · Cited by 167
Smith, G. I., Atherton, P., Villareal, D. T., Frimel, T. N., Rankin, D., Rennie, M. J., & Mittendorfer, B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001875 · Cited by 168
“myostatin [27,28] and the muscle growth factor myoD [29]).”
BackgroundTGF-β/SMAD signaling regulation of mesenchymal stem cells in adipocyte commitment
Li, S.-N., & Wu, J.-F. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-1552-y · Cited by 163
“Mstn mice also had suppressed obesity and glucose metabolism than control mice [70].”
BackgroundKishimoto, K., Washio, Y., Yoshiura, Y., Toyoda, A., Ueno, T., Fukuyama, H., Kato, K., & Kinoshita, M. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.05.055 · Cited by 163
Exercise-Released Myokines in the Control of Energy Metabolism
Laurens, C., Bergouignan, A., & Moro, C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00091 · Cited by 159
“Myostatin seems to act localy by inhibiting muscle hypertrophy, but is also secreted in the bloodstream to act remotely on adipose tissue (McPherron and Lee, 2002).”
BackgroundMyostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps
Baczek, J., Silkiewicz, M., & Wojszel, Z. B. (2020) · Nutrients · doi:10.3390/nu12082401 · Cited by 156
“Myostatin is most abundant in skeletal muscle; however, its expression was noted in cardiac muscle and in adipose tissue [51,52].”
BackgroundZhang, C., McFarlane, C., Lokireddy, S., Bonala, S., Ge, X., Masuda, S., Gluckman, P. D., Sharma, M., & Kambadur, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2079-7 · Cited by 158
“A number of studies have reported significant decreases in the amount of adipose tissue in association with loss of MSTN function [12–14].”
BackgroundBurris, T. P. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0519 · Cited by 158
Ge, G., Hopkins, D. R., Ho, W.-B., & Greenspan, D. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5846-5858.2005 · Cited by 157
“Modes of inhibition and activation of myostatin are of considerable interest, as this molecule is responsible for negative regulation of skeletal muscle growth and mass during development and in the adult (13, 16, 23, 25, 45).”
BackgroundWilkes, J. J., Lloyd, D. J., & Gekakis, N. (2009) · Diabetes · doi:10.2337/db08-0245 · Cited by 156
Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism
Schulz, T. J., & Tseng, Y.-H. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.10.019 · Cited by 154
“Deletion of myostatin, also known as GDF-8, not only confers muscle hypertrophy but also results in reduced adipose tissue mass (102;103).”
BackgroundSako, D., Grinberg, A. V., Liu, J., Davies, M. V., Castonguay, R., Maniatis, S., Andreucci, A. J., Pobre, E. G., Tomkinson, K. N., Monnell, T. E., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114959 · Cited by 152
The use of proteomics in meat science
Bendixen, E. (2005) · Meat Science · doi:10.1016/j.meatsci.2005.03.013 · Cited by 152
Myostatin: A novel insight into its role in metabolism, signal pathways, and expression regulation
Huang, Z., Chen, X., & Chen, D. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.003 · Cited by 176
Molecular and Cellular Determinants of Skeletal Muscle Atrophy and Hypertrophy
Sartorelli, V., & Fulco, M. (2004) · Science's STKE · doi:10.1126/stke.2442004re11 · Cited by 145
“Furthermore, when Mstn-null mice were bred with two different models of obesity, agouti lethal yellow [A(y)] and obese [Lep(ob/ob)], the double-mutant mice exhibited partly corrected glucose metabolism (45).”
MethodThe effects of a soluble activin type IIB receptor on obesity and insulin sensitivity
Akpan, I., Goncalves, M. D., Dhir, R., Yin, X., Pistilli, E. E., Bogdanovich, S., Khurana, T. S., Ucran, J., Lachey, J., & Ahima, R. S. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.162 · Cited by 140
“In agreement, crossing myostatin knockout mice with Lepob/ob and agouti lethal yellow (Ay/a) mice attenuated body fat and glucose levels (17).”
Double Muscling in Cattle: Genes, Husbandry, Carcasses and Meat
Fiems, L. O. (2012) · Animals · doi:10.3390/ani2030472 · Cited by 141
“However, body temperatures of MSTN null mice and wild-type mice either under normal conditions or in response to a 60-minute cold tolerance test were similar [171].”
MethodProlonged absence of myostatin reduces sarcopenia
Siriett, V., Platt, L., Salerno, M. S., Ling, N., Kambadur, R., & Sharma, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20778 · Cited by 140
“Furthermore, lack of myostatin is known to affect the physiology of TA muscle (McPherron and Lee, 2002).”
BackgroundDyle, M. C., Ebert, S. M., Cook, D. P., Kunkel, S. D., Fox, D. K., Bongers, K. S., Bullard, S. A., Dierdorff, J. M., & Adams, C. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556241 · Cited by 138
Dudáš, M., Kim, J., Li, W.-Y., Nagy, A. R., Larsson, J. T., Karlsson, S., Chai, Y., & Kaartinen, V. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.05.030 · Cited by 151
“Whereas GDF8 controls the growth of skeletal muscles (Hamrick et al., 2002; McPherron and Lee, 1997, 2002), and GDF9 is predominantly expressed in oocytes (Hanrahan et al., 2004; Carabatsos et al., 1998; Laitinen et al., 1998; McPherron and Lee, 1993), GDF11 is a likely candidate to function also…”
BackgroundPark, J.-J., Berggren, J. R., Hulver, M. W., Houmard, J. A., & Hoffman, E. P. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00045.2006 · Cited by 135
“Consistent with this model, genetically engineered GDF8 null mice also showed suppressed glucose metabolism and increased insulin signaling (30, 49).”
BackgroundSmith, F. M., Holt, L. J., Garfield, A. S., Charalambous, M., Koumanov, F., Perry, M., Bazzani, R., Sheardown, S. A., Hegarty, B. D., Lyons, R. J., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02087-06 · Cited by 134
“To investigate whether energy metabolism might be altered, mice 6 to 10 months of age were subjected to standard GTT, revealing that both Grb10 2-4m/ and Grb10 2-4m/p males and also Grb10 2-4m/p females had a significantly improved ability to clear a glucose load.”
BackgroundInfluentialPatel, K., & Amthor, H. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.10.018 · Cited by 134
Regulation of metanephric kidney development by growth/differentiation factor 11
Esquela‐Kerscher, A., & Lee, S. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00100-3 · Cited by 134
Self-citationMyostatin from the heart: local and systemic actions in cardiac failure and muscle wasting
Breitbart, A., Auger-Messier, M., Molkentin, J. D., & Heineke, J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00200.2011 · Cited by 131
“Besides the increased muscularity, the myostatin knockout mice also have reduced body fat with increasing age and are also protected against obesity triggered in genetic models (55).”
BackgroundHickford, J. G. H., Forrest, R. H.-J., Zhou, H., Fang, Q., Han, J., Frampton, C. M., & Horrell, A. L. (2009) · Animal Genetics · doi:10.1111/j.1365-2052.2009.01965.x · Cited by 157
“In addition, myostatin-deficient mice had reduced adipogenesis (Lin et al. 2002; McPherron & Lee 2002), as a result of reduced production and secretion of leptin (McPherron & Lee 2002) and tendons that were small, brittle and hypocellular (Mendias et al. 2008).”
BackgroundNunn, E., Jaiswal, N., Gavin, M., Uehara, K., Stefkovich, M., Drareni, K., Calhoun, R., Lee, M., Holman, C. D., Baur, J. A., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101880 · Cited by 126
Sun, X., & Zemel, M. B. (2007) · Lipids · doi:10.1007/s11745-007-3029-5 · Cited by 126
Mechanisms by Which Skeletal Muscle Myokines Ameliorate Insulin Resistance
Balakrishnan, R., & Thurmond, D. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094636 · Cited by 124
“Interestingly, myostatin ablation in mice skeletal muscle was also discovered to prevent fat mass gain [132].”
BackgroundAndersson, O., Korach-Andre, M., Reissmann, E., Ibáñez, C. F., & Bertolino, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800272105 · Cited by 126
“In agreement with a role in adipocyte differentiation, targeted ablation of myostatin in mice reduced accumulation of adipose tissue and weight gain in mouse models of obesity (6).”
BackgroundFournier, B., Murray, B., Gutzwiller, S., Marcaletti, S., Marcellin, D., Bergling, S., Brachat, S., Persohn, E., Pierrel, E., Bombard, F., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06575-11 · Cited by 125
“Since brown fat-enhancing therapies have a strong potential in the treatment of metabolic disorders (41), increased brown fat function most likely contributes to the protection from obesity and type 2 diabetes in various experimental settings (1, 2, 12, 23) where myostatin and ActRIIB are inhib-”
BackgroundMyostatin: more than just a regulator of muscle mass
Argilés, J. M., Orpí, M., Busquets, S., & López-Soriano, F. J. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.02.001 · Cited by 125
Exercise-induced myokines and their effect on prostate cancer
Kim, J., Galvao, D. A., Newton, R. U., Gray, E. S., & Taaffe, D. R. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00476-y · Cited by 144
Metadata
- Authors
- McPherron, A. C., & Lee, S.-J.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Lee, Se-Jin
- Venue
- Journal of Clinical Investigation
- Published
- 2002-03-01
- Volume
- 109
- Issue
- 5
- Pages
- 595-601
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4239540302
- Cited by
- 505
- References
- 31
- Citations by year
- 2026: 15 · 2025: 10 · 2024: 17 · 2023: 18 · 2022: 21 · 2021: 16 · 2020: 32 · 2019: 24 · 2018: 19 · 2017: 18 · 2016: 22 · 2015: 27 · 2014: 31 · 2013: 20 · 2012: 21
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- myostatin, Mstn knockout mice, fat deposition, obesity, type 2 diabetes, glucose metabolism, skeletal muscle hypertrophy, muscle hyperplasia, obese mice, TGF-beta superfamily
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.